Tuesday 30 September 2014

Overview of the Global Safety Syringes Market 2013 - 2019


The global safety syringes market is expected to grow at a CAGR of 9.7% between the years 2013 and 2019. This market is witnessing a shift in demand from conventional syringes to safety syringes. Safety syringes refer to syringes that are equipped with safety mechanisms. Such syringes are available with either permanently fixed needles or removable needles. The main factors that drive the global safety syringes market are better safety mechanisms in syringes, expanding injectables market, increasing frequency of needlestick injuries and government regulation on widespread use of safety syringes.

Browse the full Safety Syringes Market for Implantable Devices Report at http://www.transparencymarketresearch.com/retractable-safety-syringes.html
According to reports, millions of healthcare workers in the US are exposed to blood borne diseases caused due to injuries caused by needlesticks. Unsafe syringe handling may lead to the transfer of blood borne diseases like Hepatitis C, Hepatitis B and HIV. The global safety syringes market is fueled by greater healthcare initiatives being taken by the governments of various economies. In fact, government legislations are urging manufacturers in the global safety syringes market to produce syringes with safety mechanisms.
Market Segmentation of the Global Safety Syringes Market
The global safety syringes market is segmented primarily on the basis of product type. The two main types of safety syringes include retractable safety syringes and non-retractable safety syringes. Retractable safety syringes are also of two types which are manual retractable safety syringes and automatic retractable safety syringes. Retractable syringes include syringes with hinged needle covers, sheathing tube syringes and syringes with sliding needle covers. There is greater preference for automatic retractable safety syringes as against manual retractable safety syringes due to greater safety and ease of use. Also, the demand for retractable safety syringes is estimated to be greater than the demand for non-retractable safety syringes due to higher incidence of adoption in the developed economies and rising safety concerns.

Challenges Prevailing in the Global Safety Syringes Market


The global safety syringes may have to face some challenges in terms of simultaneous development of alternative drug delivery techniques and increasing costs associated with safety syringes. The slow rate of adoption of safety syringes across healthcare units is due to the cost of safety syringes which is twice or thrice the cost of the conventional syringes. Such a thing is more prevalent in countries which give greater importance to imparting training to healthcare workers than purchasing safety syringes for reducing the frequency of injuries caused due to needlesticks and other sharp medical instruments. Absence of strict government regulations pertaining to the use of safety syringes in the Asia Pacific and the rest of the world has been a major factor that has affected the growth of the safety syringes market in these regions.

Regional Participants in the Global Safety Syringes Market
The largest regional market for safety syringes in the global safety syringes market is North America due to the majority share that it holds in terms of both revenue and volume. The region of North America is witnessing a noteworthy shift from conventional syringes to safety syringes. In terms of volume and revenue generated in the global safety syringes market, North America is followed by Europe. The markets in the Asia Pacific and the rest of the world will also be experiencing robust growth in the global safety syringes market due to various immunization programs being undertaken by international bodies like the UNICEF and the WHO.

Some of the leading companies in the global safety syringes market include Unilife Corporation, Becton, Dickinson & Company, Retractable Technologies, Inc., Smiths Medical, Terumo Corporation, Revolutions Medical Corporation and Covidien plc.


About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com


Monday 29 September 2014

Catheters Market - Global and China Forecast, Share, Size, and Industry Analysis 2010 - 2017

Global catheters market was worth USD 20.4 billion in 2011 and is further expected to reach USD 33.3 billion in 2017, growing at a CAGR of 8.5% from 2011 to 2017. The cardiovascular catheter was the largest market segment at USD 8.3 billion in 2011. Globally, North America was the largest regional market with 44.3% share in 2011; however European region is expected to take the lead position post 2016.

Browse the full report at Catheters Market http://www.transparencymarketresearch.com/catheters-market.html

The global catheters market is expected to reach USD 22.6 billion in 2012. Aging population in both developed and emerging markets, patient's choice for minimally invasive procedures, and product innovations are key growth drivers for the market. The catheter devices market is segmented into cardiovascular, specialty, urological, neurovascular, and intravenous catheters. Among all types of catheters, cardiovascular catheters account for about 40.9% of the global catheter market.

This report analyzes the worldwide market for catheters for the period of 2010 to 2017. The in-depth research and high level analysis will allow catheters product manufacturers, service providers, marketing companies, research and development agencies to make informed decisions about catheters manufacturing, marketing, growth strategies and gaining competitive advantage.


Geographies Covered
North America
Europe
Asia-Pacific
China
Rest of the World (RoW)


Catheters Segments Covered
Cardiovascular
Neurovascular
Intravenous
Urological
Specialty


Reasons to purchase this report

This research is specially designed to estimate and analyze the demand and performance of the global and China catheters market. The report covers all the major segments of catheters market and provides in-depth analysis, market revenue, and trend analysis by segments and statistically refined forecast for the segments covered. The report also provides:

Definition, estimates & forecast for the global and China catheters market from 2010 to 2017

Market forces driving and restraining the growth of the market
Up-to-date analysis of the latest trends in the industry
Leading industry opinion keeps you abreast of latest news and trends
Forward-looking outlook on a category, market or issue affecting the industry
Make more informed business decisions from insightful and in-depth analysis of the market performance

About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

Friday 26 September 2014

Medical Imaging Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

The global medical imaging reagents market was valued at USD 10.3 billion in 2012 and is expected to grow at a CAGR of 8.8% from 2013 to 2019, to reach an estimated value of USD 18.5 billion in 2019.

Browse the full Medical Imaging Reagents Market Report at http://www.transparencymarketresearch.com/biologic-imaging-reagents-market.html

Medical imaging reagents are chemical compounds specially designed to enhance images produced through imaging systems. Medical imaging reagents allow clinicians and healthcare providers to determine whether a tumor is malignant or benign and enables to locate any metastatic cancerous sites in the body. The development of a medical imaging reagent involves synthesizing it to target a particular biological process, after which imaging systems are adjusted to neutralize the particular target. Medical imaging reagents are first studied via pre-clinical animal research before engaging in human clinical studies. The growth of the medical imaging reagents market can be attributed to the increasing demand for diagnostic and functional imaging technologies. In addition, companies in this industry are trying to stay abreast with technological innovations such as hybrid imaging modalities (e.g. SPECT + MR and PET + CT), which would alternatively boost the market growth of novel imaging reagents such as nuclear reagents and nanoparticles.

According to the Union for International Cancer Control (UICC), worldwide cancer cases are estimated to rise by almost 75% and reach approximately 25 million over the next two decades. Moreover, according to the American Cancer Society, it has been estimated that in 2014, approximately 1,665,540 new cases of cancer would be diagnosed and almost 585,720 deaths would occur due to cancer in the U.S. This increasing base of cancer patients would need advanced diagnostic imaging modalities such as photoacoustic imaging and PET+MRI as well as imaging reagents for better diagnosis, prevention and treatment of the disease, which would consequently increase the demand for medical imaging reagents.


The medical imaging reagents market has been primarily segmented by class, by technology and by applications. The medical imaging reagents class market further comprises contrast reagents, optical reagents and nuclear reagents. The contrast reagents market of the medical imaging reagents accounted for the largest market. However, among these categories, the nuclear reagents market is expected to foresee highest growth rate of over 14% from 2013 to 2019.

Moreover, medical imaging reagents technology segment comprises nanoparticles, fluorescent proteins, radiopharmaceuticals, quantum dots, fluorescent dyes and probes. The radiopharmaceuticals technology market of the medical imaging reagents accounted for the largest market due to the increased awareness about radioisotopes and high patient preference. Nevertheless, among these imaging reagent technologies, nanoparticles technology is anticipated to grow at the fastest growth rate of 9.1% from 2013 to 2019. Furthermore, medical imaging reagents application segment consists of diagnostics, drug discovery and development as well as research and development.


Among the various application areas medical imaging reagents, drug discovery and development is expected to witness the fastest growth during the forecast period owing to the growing adoption rate of medical imaging reagents in the development of nuclear medicines and medical interventions. However, diagnostics applications accounted for the largest market in terms of revenue due to the escalating patient base of cancer and cardiovascular diseases. It is expected that by the year 2019, the market value of imaging reagents for diagnostic purposes shall be worth more than USD 10 billion.


Geographically North America accounted for the largest market in the year 2012 (over 40%) followed by Europe. However, Asia Pacific is estimated to demonstrate the fastest growth rate owing to the expected rise in chronic diseases such as cancer and cardiovascular diseases coupled with rise in disposable income and growing awareness.

This market is highly consolidated in nature characterized by top five players occupying approximately 80% of the overall market share. The major players of this market include Bayer Healthcare AG, Becton Dickinson & Company, Bracco Imaging SpA, GE Healthcare, Lantheus Medical Imaging, Inc., Mallinckrodt Pharmaceuticals and Thermo Fisher Scientific, Inc.

The global medical imaging reagents market is segmented as follows:

Medical Imaging Reagents Market, by Class
Contrast Reagents
Optical Reagents
Nuclear Reagents

Medical Imaging Reagents Market, by Technology
Nanoparticles
Fluorescent proteins
Fluorescent dyes and probes
Radiopharmaceuticals
Quantum dots

Medical Imaging Reagents Market, by Applications
Diagnostics
Drug Discovery and Development
Research and Development

Medical Imaging Reagents Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

Wednesday 24 September 2014

Liver Diseases Therapeutics Market - Global Industry Analysis, Size, Share, Trends And Forecast 2012 - 2018

The global liver diseases therapeutics market was worth USD 6.5 billion in 2011 and is expected to reach USD 10.9 billion in 2018, growing at a CAGR of 8.6% from 2012 to 2018. In the overall global market, anti-viral drugs are expected to create its lead position in terms of revenue generation by 2018. Anti-viral drugs will have a share of 32.7% of the global market followed by vaccines at 19.1% in 2018.

Browse the full report at Liver Diseases Therapeutics Market http://www.transparencymarketresearch.com/liver-diseases-therapeutics.html

The major drivers of the global liver disease therapeutics market are increasing aging population inducing chronic diseases such as hepatitis and liver cancer, increasing global prevalence of liver disorder, high unmet needs existing in liver cancer and increased vaccination in emerging economies. However side-effects and risks associated with the medication, strict FDA approval norms and other government regulations and availability of alternate treatment procedures may act as the barrier for this market. Strong pipeline drugs and consolidation opportunities in the healthcare industry will pose future growth prospect for this market.

Anti-viral drugs represent the largest market in the liver disease therapeutics, which is justified by the fact that many oral, direct-acting antiviral medications are in development phase for treating hepatitis C. Currently, anti-virals are only available for hepatitis B and C. However, many anti-viral hepatitis C pipeline drugs namely GS-7977 (Nucleoside/Nucleotide polymerase inhibitor), Daclatasvir (NS5a Inhibitor), Asunaprevir (Protease Inhibitor), Simeprevie (Protease Inhibitor), and Vaniprevir (Protease Inhibitor), are expected to accelerate this market in near future.


The major players in the liver diseases therapeutics market include Astellas Pharma Inc, Gilead Science Inc, Merck & Co., Bristol-Myers Squibb, Novartis, Pfizer and Roche. In 2011, Astellas was the market leader in the immunosuppressants drugs market for liver diseases followed by Pfizer. In liver disease vaccines market, GlaxoSmithKline Pharmaceuticals Limited (GSK) represented as the major market player with a share of 45% in 2011. Bristol Myers Squibb had the largest market share in anti-viral drugs market for liver diseases followed by Gilead science in 2011.


This research is specially designed to estimate and analyze the demand for liver diseases therapeutics in global market. The research provides an in-depth analysis of the product sales, drugs class wise trend analysis and the major player pertaining to this market. High level analysis of the mentioned drug class of global liver diseases therapeutics market is performed and the report provides detailed analysis, comprehensive historical data and statistically tested forecast of the drug classes thus covered. Detailed qualitative information is given for different liver diseases and the application of different drugs as the treatment and therapy option.

Browse all Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453


Nutraceutical Ingredients Market Growth - 2017

Global nutraceutical ingredients market is expected to be worth USD 20.8 billion in 2012 and is further expected to reach USD 29.5 billion in 2017, growing at a CAGR of 7.3% from 2012 to 2017. The body building segment is expected to be the largest segment at USD 9.5 billion in 2012. In the overall global market, Asia Pacific region is expected to maintain its lead position in terms of revenue till 2017. Asia Pacific is expected to enjoy 37.5% of global nutraceutical ingredients market revenue share in 2017 followed by North America.

Browse the detailed TOC at Nutraceutical Ingredients Market http://www.transparencymarketresearch.com/nutraceutical-ingredients-market.html

Increasing number of clinical studies confirming the health benefits of nutraceuticals and their broad applications in food, beverages, dietary supplements, and pediatric and adult nutritional preparations has provided support for the growing use of nutraceutical ingredients. Moreover, faster growth in consumption of nutraceutical ingredients worldwide, especially in developing economies has boosted the growth of nutraceutical ingredient market. In addition, increasing economic prosperity in developing countries including India, China, Brazil, Mexico, Russia,South Africa, South Koreaand Poland will enable consumers to spend more on health and nutrition. This will boost the future growth of the nutraceutical ingredient market.

Major segments of nutraceutical ingredients market include Body building, weight control, diabetes control and pain relief. In 2011, body building was the largest segment followed by weight control. The controlling diabetes segment was the third largest segment, accounting for 16.5% revenue share in 2011.

Amino acids and soy-based ingredients segments of body building market witnessed healthy growth rate during the review period (from 2007 to 2011). The growth in amino acid & soy-based ingredient segment is largely attributed to increased trend of fitness in most of the developing nations. The protein and peptide segment is also expected to have steady growth rate because of growing demand for nutritional diet and proper physic all over the world.


Nutraceutical ingredients presents opportunity for new entrants as well for existing players, due to the fact that most of the raw materials are abundant and product manufacturers are increasingly focusing on contract manufacturing outsourcing (CMO). Moreover, large product manufacturers are looking for backward integration, which will grow the competition into the market and will intern increase the market size of the nutraceutical ingredients.

This report is an effort to identify factors, which will be the driving force behind the nutraceutical ingredient market and its sub-markets over the next six years. The report provides extensive analysis of the nutraceutical industry, current market trends for better understanding of the nutraceutical ingredient market. The study presents a comprehensive assessment of the global nutraceutical ingredient market on the basis of:


Body Building
Probiotics and Prebiotics
Proteins
Peptides
Amino acids
Soy-based ingredients
Omega 3


Weight Control
Fibers and carbohydrates
Minerals
Vitamins & premixes

Controlling Diabetes
Antioxidants & Carotenoids
Dairy-based Ingredients

Pain Relief
Nutritional lipids and oils
Phytochemicals & Plant extracts

Geography
North America
Western Europe
Asia Pacific
Latin America
Eastern Europe
Middle East and Africa (MEA)

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

Global and China Insulin Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019

Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, Modern and Human Insulin) - Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume), 2013 - 2019", the global insulin market was valued at USD 19.99 billion in 2012 and is expected to grow at a CAGR of 6.1% from 2013 to 2019 to reach USD 32.24 billion in 2019.

Browse the full Global and China Insulin Market Report with TOC at http://www.transparencymarketresearch.com/insulin-market.html

Rising prevalence of diabetes is one of the serious healthcare concerns on a global level. Insulin is a hormone secreted by pancreas to absorb the blood sugar. However, in diabetes, it is either not possible for the body to secrete insulin (type-1) or to utilize secreted insulin to metabolize glucose (type-2). Insulin deficiency in diabetic patients is the most important factor driving the insulin market globally. Rising prevalence of diabetes and extensive R&D activities are the other key factors boosting growth in the insulin market. No permanent cure has been invented for diabetes, thus the evolution of insulin therapy has emerged as an indispensible treatment therapy for type-1 diabetes patients.

The global and China insulin market is segmented based on source and mode of action. The insulin market by source is categorized as modern insulin and human insulin. The modern insulin segment is expected to grow at the fastest rate during the forecast period from 2013 to 2019, globally as well as in China. The insulin market by mode of action is segmented into rapid-acting, short-acting, intermediate-acting, long-acting and premixed insulin derivatives. Due to advantages over other derivatives, the long-acting derivatives segment is expected to grow rapidly during the forecast period.

Browse Press Release of Global and China Insulin Market at @ http://www.transparencymarketresearch.com/pressrelease/insulin-market.htm

The segment held the largest share of 42.77% of the total market in 2012. It is expected to be the largest segment by the end of 2019. Rapid-acting insulin was the second largest segment in 2012. Other segments such as premixed, intermediate-acting and short-acting insulin derivatives are expected to lose market share during the forecast period. This is mainly due to low patient preference and lack of R&D in these segments. Pharmaceutical companies have concentrated their R&D strategies towards long-acting and rapid-acting derivatives development, which would boost market growth.


The rapid-acting, long-acting and premixed derivatives segments are the most important segments in China. Growth in these segments is mainly attributed to rising population of type-1 diabetes and growing tendency of type-2 diabetes patients to use insulin as a therapeutic agent.

The insulin market in China is expected to grow steadily due to extensive R&D activities for the development of new insulin analogs and formulations that can be administered via different routes. Various products such as LY2605541 (Eli Lilly and Company), MK-1293 (Merck & Co., Inc.), NN1218 (Novo Nordisk A/S) and Afrezza (MannKind Corporation) are under pipeline studies and are expected to enter the market during the forecast period. Due to these new formulations, the market is likely to grow steadily during the forecast period.

Browse All Market Research Press Releases at: http://www.transparencymarketresearch.com/press-releases.htm

The insulin market is highly consolidated and dominated by select players operating on a global level such as Novo Nordisk A/S, Eli Lilly and Company, and Sanofi. In China, local and regional players such as Shanghai Fosun Pharmaceuticals Pvt. Ltd. and Tonghua Dongbao also contribute to the insulin market.


The global and China insulin market is segmented as follows:

Global and China Insulin Market, by Mode of Action
Rapid-Acting
Short-Acting
Intermediate-Acting
Premixed
Long-Acting

Global and China Insulin Market, by Source
Modern Insulin
Human Insulin

Browse All Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Tuesday 23 September 2014

Enteric Disease Testing Market is Expected to Reach to USD 3.6 Billion Globally by 2019: Transparency Market Research


The global enteric disease testing market was valued at USD 3.1 billion in 2012 and is expected to grow at a CAGR of 2.4% from 2013 to 2019, to reach an estimated value of USD 3.6 billion in 2019.

Browse the full report with complete TOC at Enteric Disease Testing Market http://www.transparencymarketresearch.com/enteric-disease-testing-market.html

Enteric diseases are major causes of morbidity and mortality worldwide. Developing socio-economic countries with poor drainage, sanitation along with overcrowding and low hygiene awareness account for majority of enteric infection incidences prevailing worldwide. These diseases usually exhibit mild symptoms but if not treated on time can lead to severe complications, resulting in death. In order to manage these diseases effectively, their early detection is essential. Various enteric diseases responsible for diarrhea, stomach pain, nausea, vomiting, anorexia, weight loss and fever are amebiasis, giardiasis, rotavirus infection, salmonellosis and shigellosis.

Traditionally, diagnosis of enteric infections relied on culture results of fecal specimen. Today, the world is witnessing a paradigm shift from culture to EIA (enzyme immunoassaya) and PCR (polymerase chain reaction) based tests owing to advantages associated with these newer testing methods.


EIA and PCR tests offer enhanced sensitivity and specificity compared to culture tests and also give quick results. Globally the market for enteric disease testing is growing at a CAGR of 2.4% under the influence of rising awareness, demand for point of care testing and increasing application of molecular diagnostics. Use of molecular diagnostic products has made diagnosis easy and possible, even those strains which once seemed to be difficult and impossible. North America and Europe represent the largest regional markets because of rapid demand for molecular based diagnostics and due to high level of awareness among people about the diseases. C.difficile infection is one of the major causes of antibiotic related diarrhea in developed regions.


Various epidemiological sources including CDC and American Association for Clinical Chemistry suggest that C.difficile infection incidence per 100,000 people has increased over the past few decades in United States. In developing nations, frequent travelling to regions where enteric diseases are epidemic is also one of the reasons driving the market growth. Asia-Pacific and Africa have been predicted to grow rapidly during the forecast period. In developing nations of Asia-pacific, Africa and Latin America, the market is also growing due to advent of rapid dipstick tests which can be applied by the patient themself. These regions associated with inadequate healthcare infrastructure do not possess substantial number of laboratories to perform laboratory based tests. Thus, rapid dipstick test kits being inexpensive and easy to use are widely accepted in these regions for managing enteric illness. Continuously improving economy and rising healthcare expenditure in these regions are also anticipated to drive the market. The market is also growing due to emergence of new strains; sources from Eurosurveillance suggest that the norovirus infection is increasing worldwide, including United Kingdom, the Netherlands, France, Japan and Australia due to emergence of new strain of genotype II.4 (GII.4) that is also known as Sydney strain.


Some of the major companies leading the market for enteric disease testing are DiaSorin, Cepheid, Bio-Rad, Trinity Biotech, Biomerica, Becton Dickinson, Meridian Bioscience, Alere and bioMerieux.

The global enteric disease testing market is segmented into the following categories:


Enteric Disease Testing Market, by types of diseases

Bacterial Enteric Disease Testing
C.difficile Infection
Campylobacteriosis
Cholera
E.coli Infection
H.pylori Infection
Salmonellosis
Shigellosis

Viral Enteric Disease Testing
Rotavirus Infection
Norovirus Infection

Parasitic Enteric Disease Testing
Amebiasis
Cryptosporidiosis
Giardiasis

Enteric Disease Testing Market, by Geography
North America
Europe
Asia-Pacific
Africa
Latin America
Rest of the World (RoW)

Browse all Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Monday 22 September 2014

Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Analysis 2014 - 2020

Hospital-acquired pneumonia also called as healthcare associated pneumonia or nosocomial pneumonia is acquired in hospital premises. Unlike community acquired pneumonia hospital acquired pneumonia is mainly caused due to multidrug resistant microorganisms. The report analyzes the market for late stage candidates for treatment of nosocomial pneumonia, and also provides a detailed review of drugs in early stages of clinical trials. The report studies and estimates market for six late stage along with an elucidation of ten early stage candidates for nosocomial pneumonia treatment.

Browse Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Report with Full TOC at http://www.transparencymarketresearch.com/hospital-acquired-pneumonia-drugs.html

Phase III candidates include tedizolid phosphate, ceftolozane/tazobactam, ceftazidime/avibactam, amikacin inhale, plazomicin and synflorix vaccine. Market for each of the investigational drugs is estimated based on current anti-microbial efficiency, historic market trend and patents of drugs from similar class, manufacturing and marketing licenses, along with competition from commercialized and pipeline drugs. Hospital acquired pneumonia drugs market for phase III candidates has been estimated from the expected year of launch till 2020. The hospital acquired pneumonia drugs market report also gives a brief review of the various drugs commercially available for treating hospital acquired pneumonia. Historic market revenue of these drugs from 2011 to 2013 has also been included. Market forecast mainly rests on a detailed event impact analysis, which considers historic as well as anticipated events which impact the market in varying degrees.

Global market for hospital acquired pneumonia drugs is mainly driven by the increasing prevalence of nosocomial infections across the globe. To illustrate this fact, the report includes a statistical comparison of the prevalence of nosocomial infections in various developed and developing countries. Geographical trend of hospital acquired pneumonia drugs market, is explains with a brief regulatory approval process, along with expected time frame for drug launch in various countries. These trends have been explained for geographical regions including North America, Europe, Asia Pacific and Rest of the World.


To gain a complete market understanding, Porters Five Force’s analysis, and value chain analysis has also been included in the hospital acquired pneumonia drugs market report. The report also explains key market drivers, restraints, opportunities in the hospital acquired pneumonia drugs market. Diagnosis, treatment, and epidemiology of hospital acquired pneumonia gives a clinical overview of the disease and current modes of disease management. Relevant recommendations have been suggested for designing successful market strategies for competing in the market.



Hospital acquired pneumonia drugs market report also includes company profiles of key market players. These include Achaogen, Inc., Aridis Pharmaceuticals, AstraZeneca plc, Cubist Pharmaceuticals, Inc., Meiji Seika Pharma Co. Ltd., Merck & Co. Ltd., Sanofi, GlaxoSmithKline, Inc., and Valneva SE. All of these players are profiled considering company overview, financial overview, product portfolio, business strategies, and recent developments.



About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453


U.S. Vaccine Market is Expected to Reach USD 17.4 Billion by 2018: Transparency Market Research


The U.S. vaccine market is estimated to be worth USD 12.8 billion in 2012 and is further expected to reach USD 17.4 billion by 2018, growing at a CAGR of 5.3% from 2012 to 2018. Human vaccine segment occupies about 80% of the U.S. vaccine market.

Browse U.S. Vaccine Market Report with Full TOC at http://www.transparencymarketresearch.com/us-vaccine-market.html

U.S. will continue to lead the global vaccine market due to rising prevalence of infectious diseases in humans and animals, and advancement in biotechnology in the region. Short functional shelf life of certain vaccines will have negative impact on the market growth, but huge product pipeline of the multinational firms will overcome this concern and will drive the future growth of the market.

Pediatric vaccine segment in the U.S. human vaccine market enjoys high share as well as high growth rate due to government compulsion for child immunization. Adult & adolescent vaccine market is expected to grow moderately over the next six years due to rising awareness and increasing vaccination for human papillomavirus (HPV) and such other viral diseases.

Livestock vaccine is the leading segment of the overall U.S. animal vaccine market accounting for 58.1% in 2012 due to more organized dairy sector and increased awareness towards prevention of infectious diseases in cattle. Bovine vaccine market is the largest revenue generating segment of the overall Livestock vaccine market in 2012 due to rising vaccination to protect breeding animals against infectious diseases. Together feline vaccine and canine vaccine accounted for about 95.1% of the overall U.S. companion animal vaccine market in 2011.

In 2011, overall leading producers of human vaccine for the U.S. market were Sanofi-Aventis, Merck, GlaxoSmithKline, Pfizer, Sanofi-Pasture and Novartis. The leading producers of animal vaccine for the U.S. market includes Pfizer Animal Health, Merial (Sanofi-Aventis), Intervet/Schering-Plough (Merck) and Novartis Animal Health.


This report helps to identify factors, which will be the driving force behind the U.S. Vaccine market and sub-markets in the next six years. The report provides extensive analysis of the U.S. vaccine market, current market trends, industry drivers and challenges for better understanding of the U.S. vaccine market structure. The report has segregated the U.S. vaccine industry in terms of its product type. Annual estimates and forecasts are provided for the period 2012 through 2018 in terms of value in USD million.

Segments Analyzed


U.S. vaccine market- by Product

Human vaccine
Pediatric Vaccines
Adult & Adolescent vaccine
Other human vaccine


Animal vaccine
Livestock vaccine
Bovine vaccine
Porcine vaccine
Ovine vaccine

Companion animal vaccine
Feline vaccine
Canine vaccine
Equine vaccine
Other animal vaccine

Browse all Pharmaceutical Market Research Reports

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453


Thursday 11 September 2014

Safety Syringes Market Growth 2013 - 2019


The global safety syringes market was valued at USD 3.41 billion in 2012 and is expected to grow at a CAGR of 9.7% from 2013 to 2019, to reach an estimated value of USD 6.50 billion by 2019.

Browse the full Safety Syringes Market for Implantable Devices Report at http://www.transparencymarketresearch.com/retractable-safety-syringes.html

Safety syringes are integrated with safety mechanisms that protect patients and healthcare professionals from accidental needlestick injuries. High risk associated with the unsafe handling of syringes that may transfer HIV, Hepatitis B, Hepatitis C and other blood borne diseases, encourages healthcare workers to adopt syringes with safety features. There are two major types of safety syringes available in the market, namely, retractable safety syringes and non-retractable safety syringes. Retractable safety syringes can be further categorized as the automatic retractable safety syringes and manual retractable safety syringes. Sheathing tube syringes equipped with sliding needle covers and hinged needle covers are the examples of non-retractable safety syringes.

Non-retractable safety syringes accounted for the larger share of the total market in 2012, both by revenue as well as volume. However, during the forecast period, retractable safety syringes are expected to experience greater demand than non-retractable safety syringes, mainly due to advantages offered by them such as improved safety, reduced time and ease of use. The market for retractable safety syringes has been anticipated to grow at a CAGR much higher than that of the syringes with protective shield during the forecast period from 2013 to 2019.

Increasing cases of needlestick injuries, governmental legislation propelling manufacturers to develop syringes with safety mechanisms and continuous growth in injectable drugs market are some major growth factors driving the market for safety syringes worldwide. A study conducted by the Centers for Disease Control and Prevention (CDC) suggests that approximately 385,000 needlestick and other sharps-related injuries occur in the U.S. each year. According to Eucomed, a group of more than 25,000 designers, manufacturers and suppliers of medical devices, nearly 1 million needlestick and sharps injuries occur in Europe each year. High incidence rate of needlestick injuries and their serious consequences encourage healthcare professionals to use syringes with safety mechanisms, thus driving the growth of the safety syringes market worldwide.


In order to ensure safety from accidental needlestick injuries, governments of various countries brought legislation in their respective countries mandating the use of safety syringes. The U.S. federal government signed the Needlestick Safety and Prevention Act into a law on November 6, 2000, compelling syringe and needle manufacturers to adopt product modifications in order to comply with the regulatory guidelines. Similarly, a legislation called TRBA 250 ensures the use of safety equipped syringes and needles across hospitals and physician offices in Germany. These legislations are expected to drive market growth by encouraging syringe companies to manufacture safety syringes in order to reduce injuries from needlestick and unsafe syringe usage. Similarly, the worldwide growth in the injectable drugs market will also drive the market growth for safety syringes.


On the other hand factors such as high product cost and availability of alternative drug delivery methods including transdermal drug delivery, nasal delivery and skin-based delivery may hamper the market growth to some extent. Geographically, North America accounted for the largest share of the overall safety syringes market in 2012 in terms of value (USD Million) as well as volume (Million Units), followed by Europe. Governmental legislation mandating the use of safety syringes across the healthcare facilities has been a key factor driving the market growth in the region. In Asia-Pacific and Rest of the World (RoW) regions, lack of strict governmental legislation regarding the use of safety syringes has been one of the major factors restraining the market growth in these regions. However, during the forecast period 2013 to 2019, growing concerns for accidental needlestick injuries will play a key role in driving the market growth in these markets. Becton Dickinson & Company, Covidien plc, Retractable, Technologies, Inc., Revolutions Medical Corporation, Smiths Medical, Terumo Corporation and Unilife Corporation are some major players operating in the safety syringes market space.


The global safety syringes market is segmented as follows:

Safety Syringes Market, by Product Type

Retractable Safety Syringes

Automatic Retractable Safety Syringes
By Revenue (USD Million)
By Volume (Million Units)

Manual Retractable Safety Syringes

By Revenue (USD Million)
By Volume (Million Units)

Non-Retractable Safety Syringes
By Revenue (USD Million)
By Volume (Million Units)

Safety Syringes Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com